Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05024175 · ClinicalTrials.gov registry record

Long-term Follow-up of Subjects Treated With CAR T Cells

A clinical trial of Adult and CAR-T, sponsored by Marcela V. Maus, M.D.,Ph.D..

Recruiting
Registry status
45
Enrollment target
1
Study location

NCT05024175 is a study of Adult and CAR-T that is actively recruiting participants, run by Marcela V. Maus, M.D.,Ph.D.. The registered enrollment target is 45 participants, below the 179-participant average among 10 other Adult trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05024175, a study of Adult and CAR-T, is actively recruiting participants, sponsored by Marcela V. Maus, M.D.,Ph.D..

RECRUITING
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of CAR T cells: NCT05660369 (DF/HCC# 22-175) and NCT06026319 (DF/HCC# 23-474).

Interventions

  • PROCEDURE Tumor Biopsy
  • DIAGNOSTIC_TEST Disease assessments
  • DIAGNOSTIC_TEST Blood test

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2023-08-07
Est. Completion 2039-08-01

Sponsor

Marcela V. Maus, M.D.,Ph.D.

8 total trials

What the Registry Record Tells You About NCT05024175

The ClinicalTrials.gov registry entry for NCT05024175 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 10 other Adult trials with a reported enrollment target (75% lower). The listed sponsor is Marcela V. Maus, M.D.,Ph.D., which has 8 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Adult appearing as the primary indexed condition, and to 3 interventions - of which Tumor Biopsy is the first listed.

NCT05024175 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05024175 about?

NCT05024175 is a clinical study titled "Long-term Follow-up of Subjects Treated With CAR T Cells". This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of CAR T cells: NCT05660369 (DF/HCC# 22-175) and NCT06026319 (DF/HCC# 23-474).

What is the current status of trial NCT05024175?

This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2023-08-07. Estimated completion is 2039-08-01.

What conditions does trial NCT05024175 study?

This clinical trial studies the following conditions: Adult, CAR-T, Long Term Adverse Effects, Duty to Follow Up, Progression-Free Survival.

What interventions are being tested in trial NCT05024175?

The interventions under investigation include: Tumor Biopsy (PROCEDURE), Disease assessments (DIAGNOSTIC_TEST), Blood test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05024175?

This trial is sponsored by Marcela V. Maus, M.D.,Ph.D., which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05024175 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.